Navigation Links
Squamous Cell Cancer Responds to SPDT Therapy

SARASOTA, Fla., Jan. 5, 2012 /PRNewswire/ -- George Miller developed an ulcer on his bottom lip that began to bleed.  His doctor sent cell scrapings to a pathologist, and diagnosed Miller with squamous cell carcinoma (SCC).  According to TMD Limited, a medical tourism company, squamous cell carcinoma is the 2nd most common cancer in humans and other animals. 

Squamous cell cancers can occur on the skin, lips, mouth, esophagus, bladder, prostate, lung,  vagina and cervix.  In 2010, there were more than 1 million new cases in the United States.  Most are removed surgically, and the site is treated with external beam radiation or internal radiation (brachytherapy).  Treatment is based on the size, type, location and depth of penetration, plus age and health condition of the patient.  Physicians often use Mohs surgery to slice off the tumor, then remove a very thin layer around the lesion to check for malignant cells.  If cancer cells are found, they slice off another layer and check again, until they reach a slice with no cancer cells.  This surgery is most commonly done on the face and hands.  Still, SCC tends to recur within 2 years at the same site, even with clean margins.

Risk factors include smoking, alcohol use and hematopoietic stem cell transplants.  Over exposure to UV rays and exposure to arsenic in water in industrial areas also raise the risk of SCC.

About 30% of mouth and throat cancers develop from the Human Papillomavirus (HPV).  Symptoms include reddish areas or lesions, often with intermittent bleeding, or ulcers with hard raised edges. 

Other lip and oral cavity cancers may present as a white or red patch or lump on the gum, tongue, tonsils or lining of the mouth, loose teeth, swelling of the jaw, sore throat, trouble swallowing and change of voice.  These cancers are often detected during a routine dental exam.  While these cancers are usually slow growing, most have already spread at the time of diagnosis.

Miller's oncologist ordered scans and labs, and discovered more squamous cell cancer in the lymph nodes in his neck and lesions in his lungs.  He suggested that Miller immediately undergo radical surgery followed by chemotherapy and radiation.  Even with treatment, there is only a 16% five year survival rate for SCC that has spread to the lungs.  Miller decided to get another opinion.

Miller sought the advice of his minister and he called a friend who had traveled to Mexico for successful cancer treatment a few years before.  After failed conventional treatment, his friend  went to  Mexico for treatments that are not available in the USA.  According to TMD Limited, over half a million Americans now travel outside the country for medical treatment each year, mainly to avoid chemotherapy and radiation treatments and their side effects.

Miller hit the internet and found dozens of sites for alternative cancer clinics.  He called several, and sent his records to about 5 clinics.  He spoke to the doctors and finally flew to Baja and toured his final 3 choices.  "I was amazed at what I found in Baja.  I toured a 20 story modern hospital, an outpatient clinic and a small inpatient clinic right on the beach.  These facilities were spotless, and the staff at each place was professional and efficient.  I finally chose the small inpatient clinic – every single staff person was smiling and friendly.  It just felt like the place I wanted to be," Miller said.

Miller chose Hope4Cancer Institute, founded by Antonio Jimenez, M.D.  The clinic has 8 physicians and only takes 10 patients at a time.  "We use a variety of aggressive natural therapies that are mainstream treatments in many countries – just not in the US.  We never use chemo or radiation.  Our treatments work quickly and have no side effects," Jimenez explained. "We treat the physical, emotional and spiritual aspects of cancer, and our success rates rival anything conventional medicine has to offer."

One of those aggressive therapies is SonoPhoto Dynamic Therapy (SPDT).  Dr. Jimenez is considered the world expert in this treatment method.   Patients are given a natural chlorophyll powder under the tongue, which is quickly absorbed by all the cells.  Within 24 hours, normal cells wash it back out, but it remains in the cancer cells.  Then sound and light frequencies are  pulsed through the body.  When sound and light hit chlorophyll, it causes photosynthesis, which is a chemical reaction that explodes free radical oxygen right into the cancer cells and kills them.  Tumors shrink up to 30% in just the first 14 days of treatment.

"I did my research," Miller explained.   "In the US, anything other than standard of care – surgery, chemotherapy and radiation – is considered 'alternative'.  Even chiropractic, acupuncture and massage are considered alternative.  What the word really means is that if it doesn't include drugs or surgery the FDA doesn't consider it effective.  Yet dozens of countries with higher success rates than the US use these treatments as front line therapy. Twenty years ago, doctors were run out of the country for using Vitamin C infusions.  Now they are done by medical doctors all over the country.  Hopefully someday we'll learn that drugs aren't always the answer, and these more natural therapies will become the norm.  Our medical establishment just hasn't caught up yet."

Miller's protocol included local and whole body hyperthermia, SonoPhoto Dynamic Therapy, IVs, vaccines, detoxification, nutrition, immune support, biological dentistry and lifestyle counseling.  "They gave me tools to work with," he said.   "They taught me about nutrition, and they warned me that if I went home and had a soda pop and donuts for breakfast, my cancer would probably come back.  I'm exercising, eating right and have taken steps to reduce stress. I quit smoking, and stopped eating junk food. My latest tests are clean, and I'm confident I will stay healthy.  And for anyone contemplating radical surgery – I recommend doing your homework!" Miller advised.

Author Marla Manhart is a health writer and patient advocate.  She is a member of the Oncozine Journal Writers Group and is affiliated with TMD Limited.


Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Top-Line Results Announced of Pivotal Phase 3 Motesanib Trial in Advanced Non-Squamous Non-Small Cell Lung Cancer Patients
2. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
3. BioStorage Technologies Partners with Susan G. Komen for the Cure Tissue Bank at IU Simon Cancer Center to Raise Money and Awareness for Breast Cancer Research
4. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
5. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
6. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
7. Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Efficacy Data Against Lymphoid Cancers at the 53rd Annual Meeting of the American Society of Hematology (ASH)
8. Agendia to Present Five Abstracts at 2011 San Antonio Breast Cancer Symposium
9. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
10. Novartis Highlights Advances for Patients With Breast Cancer and Hematological Diseases With Over 160 SABCS and ASH Abstracts
11. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a ... biotechnology industries to improve patient outcomes and quality of life, will now be ... are being attributed to new regulatory requirements for all new drug products, including ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... pathology, announced today it will be hosting a Webinar titled, “Pathology is going ... Pathology Associates , on digital pathology adoption best practices and how Proscia improves ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased ... of over 5.5 million people each year. Especially those living in larger cities are ... - based in one of the most pollution-affected countries globally - decided to take ...
Breaking Biology Technology:
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
Breaking Biology News(10 mins):